Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
News226
Events 10/07/2022

Secerna welcomes budding attorneys

News224
Events 01/07/2022

Global recognition for Secerna

News225
Industry news, News 01/07/2022

Routes to Accelerated Prosecution at the UKIPO

Brain With Cogs Jan 2022
Team news 22/06/2022

Celebrating Women in Engineering

News222
Industry news, News 09/06/2022

Intellectual Property and Tech Transfer

Image 2
Industry news 01/06/2022

How has intellectual property changed during The Queen's reign?

Image 3
Events 17/05/2022

Secerna to attend BIO International 2022

News218
Team news 10/05/2022

Secerna celebrates an international anniversary

News217
Events, News 05/05/2022

IP and Youth: Innovating for a Better Future on World IP Day 2022

19 20 21 22 23 24 25 26 27 28 29